You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

Citation Tools

Article menu

Download PDFPDF

Short Report
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Kaufman HL, Russell JS, Hamid O, et al
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
Journal for ImmunoTherapy of Cancer 2018;6:7. doi: 10.1186/s40425-017-0310-x